Wall Street RegretsThe regret calculator.

What if you'd held INO?

A $1,000 investment in Inovio Pharmaceuticals, Inc. (INO) at the month-end close of 1998-12 would be worth $2.04 at the close of 2026-08 — -99.8% total return, dividends reinvested. The same $1,000 in the S&P 500 would be worth $6,271.

$1,000 since 1998$2.04Total return-99.8%Multiple0.00×CAGR-20.1%

Your scenario

Dates resolve to the nearest month-end close.
Leave empty for "held until today".
Invested at each month-end. Starts on the buy date.

Result

Worth$2.04Gain+$-998 (-99.8%)Multiple0.0×CAGR-20.1%

    If you'd bought $1,000 at the start of each year

    Value of $1,000 invested on January 1 of each year, held to 2026-08, dividends included.

    2000$2.082001$7.222002$10.582003$25.082004$5.422005$6.872006$11.932007$8.232008$29.442009$52.082010$23.762011$23.552012$62.982013$54.172014$9.342015$11.802016$16.122017$15.612018$26.232019$27.082020$32.832021$12.242022$21.712023$69.442024$2122025$7102026$747

    Every year, $1,000 from 1998

    YearValue of $1,000Year return
    1998$1,000
    1999$981-1.9%
    2000$283-71.2%
    2001$193-31.7%
    2002$81.51-57.8%
    2003$377+363.0%
    2004$297-21.2%
    2005$171-42.4%
    2006$248+44.9%
    2007$69.43-72.0%
    2008$39.25-43.5%
    2009$86.04+119.2%
    2010$86.79+0.9%
    2011$32.45-62.6%
    2012$37.74+16.3%
    2013$219+480.0%
    2014$173-20.9%
    2015$127-26.8%
    2016$131+3.3%
    2017$77.92-40.5%
    2018$75.47-3.1%
    2019$62.26-17.5%
    2020$167+168.2%
    2021$94.15-43.6%
    2022$29.43-68.7%
    2023$9.62-67.3%
    2024$2.88-70.1%
    2025$2.74-4.9%
    2026$2.04-25.3%

    Best and worst month-end to buy

    The best single month-end close to have bought INO was 2026-07 ($0.68): $1,000 then is $1,912 today. The worst was 2000-02 ($1,416): $1,000 then is $0.92.

    FAQ

    What would $1,000 in INO be worth today?

    A $1,000 investment in Inovio Pharmaceuticals, Inc. (INO) at the start of 1998 would be worth about $2.04 today, a total return of -99.8%. Dividends are reinvested in these figures.

    What were the best and worst years for INO?

    Inovio Pharmaceuticals, Inc. (INO)'s strongest calendar year since 1998 was 2013, a +480.0% return — $1,000 held through that year became about $5,800 by year-end. Its weakest year was 2007, at -72.0%.

    Does the calculator include dividends and splits?

    Yes where available. Prices are adjusted for both stock splits and reinvested dividends (total return), the same measure brokerages use.

    How much would $100 per month in INO have grown?

    Investing $100 at the end of every month since 1998-12 would have grown to about $2,759 on $33,300 invested.

    Did INO beat the S&P 500?

    Over the same period, $1,000 in the S&P 500 index would be worth $6,271. INO trailed the S&P 500 by +100.0% in total return.

    Is this investment advice?

    No. Wall Street Regrets is an entertainment and education tool. Every number is a historical calculation, not a prediction, and past performance never guarantees future results.

    Methodology

    Inovio Pharmaceuticals, Inc. (INO) historical total-return data from 1998-12 to 2026-08, reduced to month-end closes for the tables above.

    Returns use adjusted close prices from Yahoo Finance historical data — adjusted for stock splits and reinvested dividends — the same convention used by major brokerages. A "year" scenario invests $1,000 at the prior December's month-end close and values it at the latest available month-end close. Non-USD amounts are converted at historical month-end exchange rates (Yahoo Finance): to USD on the buy date and back to your currency at the latest rate, so the return reflects the currency move as well as the asset.

    Month-end resolution means intra-month extremes are not captured in tables; the calculator uses exact trading-day closes where daily data is available. Figures ignore taxes, fees, and the currency effects of non-USD listings. History is not a forecast. Wall Street Regrets is entertainment, not investment advice.

    Full methodology →

    What if you'd held…

    Data: adjusted close prices via Yahoo Finance. As of 2026-08. Not financial advice.